201 related articles for article (PubMed ID: 26066997)
1. Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model.
Browne P; Judson RS; Casey WM; Kleinstreuer NC; Thomas RS
Environ Sci Technol; 2015 Jul; 49(14):8804-14. PubMed ID: 26066997
[TBL] [Abstract][Full Text] [Related]
2. Using in vitro high throughput screening assays to identify potential endocrine-disrupting chemicals.
Rotroff DM; Dix DJ; Houck KA; Knudsen TB; Martin MT; McLaurin KW; Reif DM; Crofton KM; Singh AV; Xia M; Huang R; Judson RS
Environ Health Perspect; 2013 Jan; 121(1):7-14. PubMed ID: 23052129
[TBL] [Abstract][Full Text] [Related]
3. Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches.
Zhang L; Sedykh A; Tripathi A; Zhu H; Afantitis A; Mouchlis VD; Melagraki G; Rusyn I; Tropsha A
Toxicol Appl Pharmacol; 2013 Oct; 272(1):67-76. PubMed ID: 23707773
[TBL] [Abstract][Full Text] [Related]
4. A predictive data-driven framework for endocrine prioritization: a triazole fungicide case study.
Paul Friedman K; Papineni S; Marty MS; Yi KD; Goetz AK; Rasoulpour RJ; Kwiatkowski P; Wolf DC; Blacker AM; Peffer RC
Crit Rev Toxicol; 2016 Oct; 46(9):785-833. PubMed ID: 27347635
[TBL] [Abstract][Full Text] [Related]
5. Chemistry domain of applicability evaluation against existing estrogen receptor high-throughput assay-based activity models.
Nelms MD; Antonijevic T; Ring C; Harris DL; Bever RJ; Lynn SG; Williams D; Chappell G; Boyles R; Borghoff S; Edwards SW; Markey K
Front Toxicol; 2024; 6():1346767. PubMed ID: 38694816
[TBL] [Abstract][Full Text] [Related]
6. Key lessons from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 male and female pubertal assays.
Stump DG; O'Connor JC; Lewis JM; Marty MS
Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):43-62. PubMed ID: 24510766
[TBL] [Abstract][Full Text] [Related]
7. CoMPARA: Collaborative Modeling Project for Androgen Receptor Activity.
Mansouri K; Kleinstreuer N; Abdelaziz AM; Alberga D; Alves VM; Andersson PL; Andrade CH; Bai F; Balabin I; Ballabio D; Benfenati E; Bhhatarai B; Boyer S; Chen J; Consonni V; Farag S; Fourches D; García-Sosa AT; Gramatica P; Grisoni F; Grulke CM; Hong H; Horvath D; Hu X; Huang R; Jeliazkova N; Li J; Li X; Liu H; Manganelli S; Mangiatordi GF; Maran U; Marcou G; Martin T; Muratov E; Nguyen DT; Nicolotti O; Nikolov NG; Norinder U; Papa E; Petitjean M; Piir G; Pogodin P; Poroikov V; Qiao X; Richard AM; Roncaglioni A; Ruiz P; Rupakheti C; Sakkiah S; Sangion A; Schramm KW; Selvaraj C; Shah I; Sild S; Sun L; Taboureau O; Tang Y; Tetko IV; Todeschini R; Tong W; Trisciuzzi D; Tropsha A; Van Den Driessche G; Varnek A; Wang Z; Wedebye EB; Williams AJ; Xie H; Zakharov AV; Zheng Z; Judson RS
Environ Health Perspect; 2020 Feb; 128(2):27002. PubMed ID: 32074470
[TBL] [Abstract][Full Text] [Related]
8. High-Throughput H295R Steroidogenesis Assay: Utility as an Alternative and a Statistical Approach to Characterize Effects on Steroidogenesis.
Haggard DE; Karmaus AL; Martin MT; Judson RS; Setzer RW; Paul Friedman K
Toxicol Sci; 2018 Apr; 162(2):509-534. PubMed ID: 29216406
[TBL] [Abstract][Full Text] [Related]
9. Environmental impact on vascular development predicted by high-throughput screening.
Kleinstreuer NC; Judson RS; Reif DM; Sipes NS; Singh AV; Chandler KJ; Dewoskin R; Dix DJ; Kavlock RJ; Knudsen TB
Environ Health Perspect; 2011 Nov; 119(11):1596-603. PubMed ID: 21788198
[TBL] [Abstract][Full Text] [Related]
10. Development of an In Vitro Human Thyroid Microtissue Model for Chemical Screening.
Deisenroth C; Soldatow VY; Ford J; Stewart W; Brinkman C; LeCluyse EL; MacMillan DK; Thomas RS
Toxicol Sci; 2020 Mar; 174(1):63-78. PubMed ID: 31808822
[TBL] [Abstract][Full Text] [Related]
11. Identification of nonmonotonic concentration-responses in Tox21 high-throughput screening estrogen receptor assays.
Shi Z; Xia M; Xiao S; Zhang Q
Toxicol Appl Pharmacol; 2022 Oct; 452():116206. PubMed ID: 35988584
[TBL] [Abstract][Full Text] [Related]
12. Weight of evidence for cross-species conservation of androgen receptor-based biological activity.
Vliet SMF; Markey KJ; Lynn SG; Adetona A; Fallacara D; Ceger P; Choksi N; Karmaus AL; Watson A; Ewans A; Daniel AB; Hamm J; Vitense K; Wolf KA; Thomas A; LaLone CA
Toxicol Sci; 2023 May; 193(2):131-145. PubMed ID: 37071731
[TBL] [Abstract][Full Text] [Related]
13. Machine Learning Models for Estrogen Receptor Bioactivity and Endocrine Disruption Prediction.
Zorn KM; Foil DH; Lane TR; Russo DP; Hillwalker W; Feifarek DJ; Jones F; Klaren WD; Brinkman AM; Ekins S
Environ Sci Technol; 2020 Oct; 54(19):12202-12213. PubMed ID: 32857505
[TBL] [Abstract][Full Text] [Related]
14. Potential of ToxCast Data in the Safety Assessment of Food Chemicals.
Punt A; Firman J; Boobis A; Cronin M; Gosling JP; Wilks MF; Hepburn PA; Thiel A; Fussell KC
Toxicol Sci; 2020 Apr; 174(2):326-340. PubMed ID: 32040188
[TBL] [Abstract][Full Text] [Related]
15. The Next Generation Blueprint of Computational Toxicology at the U.S. Environmental Protection Agency.
Thomas RS; Bahadori T; Buckley TJ; Cowden J; Deisenroth C; Dionisio KL; Frithsen JB; Grulke CM; Gwinn MR; Harrill JA; Higuchi M; Houck KA; Hughes MF; Hunter ES; Isaacs KK; Judson RS; Knudsen TB; Lambert JC; Linnenbrink M; Martin TM; Newton SR; Padilla S; Patlewicz G; Paul-Friedman K; Phillips KA; Richard AM; Sams R; Shafer TJ; Setzer RW; Shah I; Simmons JE; Simmons SO; Singh A; Sobus JR; Strynar M; Swank A; Tornero-Valez R; Ulrich EM; Villeneuve DL; Wambaugh JF; Wetmore BA; Williams AJ
Toxicol Sci; 2019 Jun; 169(2):317-332. PubMed ID: 30835285
[TBL] [Abstract][Full Text] [Related]
16. Respirometric Screening and Characterization of Mitochondrial Toxicants Within the ToxCast Phase I and II Chemical Libraries.
Hallinger DR; Lindsay HB; Paul Friedman K; Suarez DA; Simmons SO
Toxicol Sci; 2020 Jul; 176(1):175-192. PubMed ID: 32374859
[TBL] [Abstract][Full Text] [Related]
17. Application of the Key Characteristics Framework to Identify Potential Breast Carcinogens Using Publicly Available
Kay JE; Brody JG; Schwarzman M; Rudel RA
Environ Health Perspect; 2024 Jan; 132(1):17002. PubMed ID: 38197648
[TBL] [Abstract][Full Text] [Related]
18. A 50-gene biomarker identifies estrogen receptor-modulating chemicals in a microarray compendium.
Corton JC; Matteo G; Chorley B; Liu J; Vallanat B; Everett L; Atlas E; Meier MJ; Williams A; Yauk CL
Chem Biol Interact; 2024 May; 394():110952. PubMed ID: 38570061
[TBL] [Abstract][Full Text] [Related]
19. Optimizing androgen receptor prioritization using high-throughput assay-based activity models.
Bever RJ; Edwards SW; Antonijevic T; Nelms MD; Ring C; Harris D; Lynn SG; Williams D; Chappell G; Boyles R; Borghoff S; Markey KJ
Front Toxicol; 2024; 6():1347364. PubMed ID: 38529103
[No Abstract] [Full Text] [Related]
20. Predictive modeling of estrogen receptor agonism, antagonism, and binding activities using machine- and deep-learning approaches.
Ciallella HL; Russo DP; Aleksunes LM; Grimm FA; Zhu H
Lab Invest; 2021 Apr; 101(4):490-502. PubMed ID: 32778734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
